News | News By Subject | News by Disease News By Date | Search News

Chemotherapy/Radiation News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
MEI Pharma (MSHL)'s Pracinostat Called a Breakthrough By the FDA     8/1/2016
Bay Area's Heron (HRTX) Surges as the FDA Finds No Deficiency with SUSTOL NDA, Starts Labeling Discussions     4/19/2016
UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma for $1.14 Billion     3/7/2016
Heron (HRTX)'s Sustol Finally Gets a Date with the FDA     3/3/2016
FDA Needs More Time, Delays Assigning Action Date for Heron (HRTX)'s SUSTOL NDA     2/29/2016
Top 10 Best-Selling Biotech Drugs     10/2/2015
Merrimack (MACK) Ramps Up Sales Force in Anticipation of Regulatory Approval of Pancreatic Cancer Drug     9/10/2015
Tesaro (TSRO) Wins FDA Nod for Chemotherapy-Induced Nausea Drug Varubi     9/2/2015
Bay Area's Heron (HRTX) Rockets as Nausea Drug Meets Goals in Phase III Study     6/1/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Eisai Inc. (ESALF.PK) Drug For Chemotherapy-Associated Nausea     10/10/2014
FDA Green Lights Eisai Inc. (ESALF.PK)'s ALOXI ®To Prevent Nausea And Vomiting Due To Chemotherapy In Kids     5/29/2014
Tesaro, Inc. (TSRO) Announces Successful Achievement Of Primary And All Secondary Endpoints In Third And Final Phase 3 Trial Of Rolapitant     5/13/2014

News from Around the Web
Pharma's Big New Cancer Drug May Be An Old Red Dye     2/26/2016
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Cocktail of Chemotherapy Drugs Improves Survival with Pancreatic Cancer, Nancy University Study     5/12/2011
Natural Protection Against Radiation, Study Published in ACS Medicinal Chemistry Letters     5/4/2011
Banking Stem Cells Could Save Japan Nuclear Workers, Japanese Foundation for Cancer Research Suggests     4/15/2011
Japan's Nuclear Contamination Spreads to More U.S. States, EPA Finds     3/29/2011
Fish Oil Fights Wasting During Chemo, University of Alberta Study     2/28/2011
Pot Ingredient May Restore Appetite After Chemo, University of Alberta Study     2/24/2011
High Response Rates Seen In Phase-III Trial Of Chemotherapy, New Drug And Stem Cells In Myeloma, Azienda Ospedaliera Universitaria San Giovanni Battista of Torino Study     10/14/2010
Erlotinib Trumps Chemo in Advanced NSCLC With EGFR Mutations, Tongji University Study     10/12/2010
Babies With Common Cancer Live as Long With Less Chemotherapy, University of California, San Francisco (UCSF) Study Finds     10/1/2010
Ancient Brew May Reduce Gut Damage after Chemotherapy, Yale University Reveals     8/19/2010
Lifesaving Cancer Drugs May Put Workers' Lives At Risk     7/12/2010
Milk Thistle May Limit Liver Damage From Chemo, Columbia-Presbyterian Medical Center Study     12/15/2009
Finding May Help Some Tonsil Cancer Patients Avoid Chemotherapy, Princess Margaret Hospital Study     11/6/2009

Press Releases
DelMar Pharma Delivers An Address And Presents An Overview Of Upcoming GBM Trials With VAL-083 At The CNS Anticancer Drug Discovery Development Conference And Society For NeuroOncology Annual Meeting     11/21/2016
Saladax Biomedical Inc. (SBI) Release: Recent Study Shows Chemotherapy Toxic Effects Reduced Through Personalized Dosing     11/15/2016
RadioMedix Successfully Completed The Phase I/ II Clinical Studies For Aminomedix Used For Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT)     10/20/2016
St. Jude Children's Research Hospital Release: Triple-Drug Chemotherapy With Topotecan Helps Preserve Vision In Retinoblastoma Patients     10/11/2016
Peregrine (PPHM) Reports Top-Line And Initial Biomarker Data From Phase III SUNRISE Trial Of Bavituximab In Oral Presentation At European Society For Medical Oncology (ESMO) 2016 Congress     10/10/2016
Amgen (AMGN) Release: New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin     10/10/2016
DelMar Pharma Presents Data Supporting The Potential Of VAL-083 As A New Treatment For Ovarian Cancer At The 11th Biennial Ovarian Cancer Research Symposium     9/13/2016
DelMar Pharma And Accurexa To Collaborate In The Development Of A Novel Combination Chemotherapy For The Local Treatment Of Brain Cancer     9/7/2016
MorphoSys AG Initiates Phase 2/3 Trial Of CD19 Antibody MOR208 Plus Bendamustine In Patients With Relapsed Or Refractory DLBCL     9/6/2016
Heron (HRTX) Announces FDA Approval Of SUSTOL (Granisetron) Extended-Release Injection For The Prevention Of Chemotherapy-Induced Nausea And Vomiting     8/10/2016
Veritas Pharma Inc Reaches Important Scientific Milestone; Animal Studies Fully Underway To Evaluate The Safety And Effectiveness Of Cannabis Strains     8/10/2016
Shasqi Local Drug Activation Technology Provides Improved Drug Efficacy With Minimal Side-Effects     7/21/2016
OncoGenex (OGXI) Reports Financial Results For First Quarter 2016     5/13/2016
American Urological Association Release: Study Suggests Chemotherapy After Radical Prostatectomy May Benefit Men Who Are At High Risk For Relapse     5/9/2016
Oncolytics Biotech Inc. (ONC.TO) Announces 2016 First Quarter Results     5/6/2016

//-->